Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic Surgery and Diabesity: a Systematic Review.

Literature DB >> 29679334

Metabolic Surgery and Diabesity: a Systematic Review.

Lionel El Khoury¹, Elie Chouillard¹, Elias Chahine¹, Elias Saikaly², Tarek Debs³, Radwan Kassir^4,5.

Abstract

Bariatric surgery is used to induce weight loss (baros = weight). Evidence has shown that bariatric surgery improves the comorbid conditions associated with obesity such as hypertension, hyperlipidemia, and type 2 diabetes mellitus T2DM. Hence, shifting towards using metabolic surgery instead of bariatric surgery is currently more appropriate in certain subset of patients. Endocrine changes resulting from operative manipulation of the gastrointestinal tract after metabolic surgery translate into metabolic benefits with respect to the comorbid conditions. Other changes include bacterial flora rearrangement, bile acids secretion, and adipose tissue effect. The aim of this systematic review is to examine clinical trials regarding long-term effects of bariatric and metabolic surgery on patients with T2DM and to evaluate the potential mechanisms leading to the improvement in the glycaemic control.

Entities: Chemical Disease Species

Keywords: Diabesity; Metabolic surgery; Obesity; Type 2 diabetes mellitus

Mesh：

Substances：
Blood Glucose

Year: 2018 PMID： 29679334 DOI： 10.1007/s11695-018-3252-6

Source DB: PubMed Journal: Obes Surg ISSN： 0960-8923 Impact factor: 4.129

93 in total

1. Five-year outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding.

Authors: Samuel Sultan; Deepali Gupta; Manish Parikh; Heekoung Youn; Marina Kurian; George Fielding; Christine Ren-Fielding
Journal: Surg Obes Relat Dis Date: 2010-03-01 Impact factor: 4.734

Review 2. Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

Authors: Hutan Ashrafian; Carel W le Roux
Journal: Physiol Behav Date: 2009-03-20

3. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.

Authors: Stephanie Troy; Maud Soty; Lara Ribeiro; Laure Laval; Stéphanie Migrenne; Xavier Fioramonti; Bruno Pillot; Veronique Fauveau; Roberte Aubert; Benoit Viollet; Marc Foretz; Jocelyne Leclerc; Adeline Duchampt; Carine Zitoun; Bernard Thorens; Christophe Magnan; Gilles Mithieux; Fabrizio Andreelli
Journal: Cell Metab Date: 2008-09 Impact factor: 27.287

4. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.

Authors: Tom C Hall; Mike G C Pellen; Peter C Sedman; Prashant K Jain
Journal: Obes Surg Date: 2010-09 Impact factor: 4.129

5. Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors: K Tatemoto; M Carlquist; V Mutt
Journal: Nature Date: 1982-04-15 Impact factor: 49.962

6. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes.

Authors: Chih-Cheng Hsu; Abdullah Almulaifi; Jung-Chien Chen; Kong-Han Ser; Shu-Chun Chen; Kai-Ci Hsu; Yi-Chih Lee; Wei-Jei Lee
Journal: JAMA Surg Date: 2015-12 Impact factor: 14.766

7. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245

8. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.

Authors: G Mingrone
Journal: Nutr Metab Cardiovasc Dis Date: 2008-10 Impact factor: 4.222

9. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity.

Authors: Michael G Sarr; Charles J Billington; Roy Brancatisano; Anthony Brancatisano; James Toouli; Lilian Kow; Ninh T Nguyen; Robin Blackstone; James W Maher; Scott Shikora; Dominic N Reeds; J Christopher Eagon; Bruce M Wolfe; Robert W O'Rourke; Ken Fujioka; Mark Takata; James M Swain; John M Morton; Sayeed Ikramuddin; Michael Schweitzer; Bipan Chand; Raul Rosenthal
Journal: Obes Surg Date: 2012-11 Impact factor: 4.129

10. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.

Authors: Ricardo V Cohen; Jose C Pinheiro; Carlos A Schiavon; João E Salles; Bernardo L Wajchenberg; David E Cummings
Journal: Diabetes Care Date: 2012-07 Impact factor: 19.112

6 in total

Review 1. Bariatric surgery for the management of type 2 diabetes mellitus-current trends and challenges: a review article.

Authors: Mansur Suliman Alqunai; Fauwaz Fahad Alrashid
Journal: Am J Transl Res Date: 2022-02-15 Impact factor: 4.060

Review 2. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.

Authors: Avner Leshem; Nir Horesh; Eran Elinav
Journal: Front Immunol Date: 2019-06-14 Impact factor: 7.561

3. A Comparative Study of the Effect of Two Procedures of Classic Roux-en-Y and Omega Bariatric Surgery on the Control and Management of Diabetes.

Authors: Masoud Sayadi Shahraki; Mohsen Mahmoudieh; Behrooz Keleidari; Hamid Melali; Abdulhakim Algazali
Journal: Adv Biomed Res Date: 2022-05-30